IQQ4:F:F- (EUR)

ETF | Others |

Last Closing

USD 17.48

Change

-0.10 (-0.58)%

Market Cap

USD 0.32B

Volume

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.20 (+0.74%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.79%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.43 (+0.78%)

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.36 (-0.07%)

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

N/A

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.15 (+0.66%)

USD 71.25B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.95 (+0.41%)

USD 56.96B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.07 (+0.07%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.08 (+0.09%)

USD 51.63B

ETFs Containing IQQ4:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.59% 12% F 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.59% 10% F 30% F
Trailing 12 Months  
Capital Gain -9.66% 15% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.66% 12% F 34% F
Trailing 5 Years  
Capital Gain -34.12% 2% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.12% 2% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain -5.86% 13% F 29% F
Dividend Return -5.86% 11% F 26% F
Total Return N/A 28% F 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 12.75% 52% F 79% B-
Risk Adjusted Return -45.96% 24% F 26% F
Market Capitalization 0.32B 50% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.